Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Understanding what makes a crypto exchange secure is crucial for traders. Explore the key factors that ensure safety in trading.
15,153 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
When an executive sells stock, investors ask whether it signals trouble or simply personal liquidity needs. This guid...
In 2026, several of Vanguard's sector ETFs are outperforming the S&P 500. This guide explains why, highlights a March...
Fidelity's Dividend ETF for Rising Rates has surged 23% over the last year, but the fund’s tech-heavy, rate-sensitive...
In a volatile market, Mastercard and Visa are reinforcing their status as durable, long-term holdings. A growing paym...
A major move by a prominent asset manager reveals how large portfolios tweak biotech bets. Learn what the trim means ...
The euro sits around $1.16, reshaping how three Europe-focused ETFs approach currency risk. US investors must weigh e...
A practical guide to Warner Music’s 2026 outlook for investors. Explore growth drivers, margins, and the risks that c...
SpaceX IPO excitement can tempt any investor, but the space sector is risky and competitive. This guide compares Spac...
As oil reserves dwindle, two big trends are shaping energy markets in 2026. This article breaks down what to watch, w...
NVDY is pursuing income by selling Nvidia’s strongest move days, financing a roughly 60% distribution. The strategy b...
If you’re hunting for reliable dividend income, AbbVie and Pfizer are two top contenders. This guide breaks down whic...